Engaging with other key Policy debates

Apart from specific endocrine related health policy aspects, ESE also raises the voice of endocrinology in other policy debates with an impact on health and endocrinology. As a member of the BioMed Alliance, ESE jointly engages with other scientific and medical societies in the discussions around e.g. the European Health Data Space or the upcoming EU Regulation on In Vitro Diagnostic Medical Devices (IVDR), that may have an important impact on data collection for research purposes or on the functioning of clinical and research laboratories, respectively.

3 August 2021: ESE Joint Statement with ESPE, Endo-ERN & EuRRECa on the European Health Data Space Consultation. European Health Data Space Consultation - Joint statement on behalf of The European Society of Endocrinology (ESE), The European Society for Paediatric Endocrinology (ESPE), The European Reference Network on rare endocrine conditions (Endo-ERN) and the European Registries for Rare Endocrine Conditions (EuRRECa)

The four signatories welcome the European Health Data Space (EHDS) Initiative to further facilitate health-data exchange within and across European countries. If implemented correctly, this will boost innovative medical research, improve patient’s access to their personal data, improve the diagnosis and care for patients across Europe and inform European as well as national health related policies.

30 July 2021: Ticking bomb - The implementation of the new EU Regulation for In Vitro Diagnostic Medical Devices (IVDR). HAVE YOUR SAY! 

The BioMed Alliance Taskforce on IVD in collaboration with the European Haematology Association Taskforce on IVD have elaborated a questionnaire on the current use of different IVD tests in diagnostic laboratories. The objective of the questionnaire is to gain insight into the current situation for medical laboratories, in particular the degree of (un)preparedness of medical laboratories for the IVDR implementation, and to make an accurate assessment of the potential impact that the IVDR will have on diagnostic laboratories and their test menu. They requested diagnostic laboratories in the EU to fill in this questionnaire on their current use of IVD tests and their preparations for the IVDR (the new EU regulation on in vitro diagnostic medical devices).